Action Point Financial Planning’s Intellia Therapeutics NTLA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-5
Closed -$85 – 1817
2026
Q2
$85 Buy
+5
New +$70 ﹤0.01% 2734

Other funds holding NTLA

Action Point Financial Planning's NTLA Position: Q3 2026 in Review

Action Point Financial Planning sold out of Intellia Therapeutics (NTLA) in Q3 2026, closing a stake of 5 shares — an estimated $85 sold.

Action Point Financial Planning first reported a position in NTLA in Q2 2026 and held it in 1 quarter. The position peaked at $85 in Q2 2026. 312 funds tracked by Wall St. Rank hold NTLA as of Q3 2026.

  • Action Point Financial Planning reported no remaining Intellia Therapeutics position as of Q3 2026 after selling out during the quarter.
  • Action Point Financial Planning sold 5 Intellia Therapeutics shares in Q3 2026, an estimated $85.
  • Action Point Financial Planning first reported a position in Intellia Therapeutics in Q2 2026 and held it in 1 quarter.
  • Action Point Financial Planning's Intellia Therapeutics position peaked at $85 in Q2 2026.
  • 312 funds tracked by Wall St. Rank held Intellia Therapeutics as of Q3 2026.

Based on Action Point Financial Planning's 13F filing for Q3 2026, filed 13 Nov 2026.